Patents by Inventor Ana Fernandes

Ana Fernandes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for treating a mammal by administration of a compound having the ability to release CO
    Publication number: 20070207217
    Abstract: The present invention relates to molybdenum carbonyl complexes useful for inhibiting tumor necrosis factor (TNF) production and for treating inflammatory diseases.
    Type: Application
    Filed: December 20, 2006
    Publication date: September 6, 2007
    Applicant: Alfama - Investigacao e Desenvolvimento De Productos Farmaceuticos Lda
    Inventors: Werner Haas, Carlos Romao, Sandra Rodrigues, Joao Seixas, Ana Pina, Beatriz Royo, Ana Fernandes, Isabel Goncalves
  • Method for treating a mammal by administration of a compound having the ability to release CO
    Publication number: 20060233890
    Abstract: Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases with a strong inflammatory component, such as atherosclerosis, stroke, coronary disease, and Alzheimers disease. The in vivo carbon monoxide-releasing compounds can be attached to known drug vectors and/or known anti-inflammatory drugs, such as aspirin.
    Type: Application
    Filed: June 14, 2006
    Publication date: October 19, 2006
    Applicant: Alfama - Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda
    Inventors: Werner Haas, Carlos Romao, Beatriz Royo, Ana Fernandes, Isabel Goncalves
  • Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
    Publication number: 20060148900
    Abstract: Several classes of in vivo carbon monoxide-releasing compounds are useful for the treatment and/or prevention of diseases, such as chronic inflammatory, e.g., rheumatoid arthritis, and of diseases with a strong inflammatory component, such as atherosclerosis, stroke, coronary disease, and Alzheimers disease. The in vivo carbon monoxide-releasing compounds can be attached to known drug vectors and/or known anti-inflammatory drugs, such as aspirin.
    Type: Application
    Filed: November 29, 2005
    Publication date: July 6, 2006
    Applicant: Alfama - Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda
    Inventors: Werner Haas, Carlos Romao, Beatriz Royo, Ana Fernandes, Isabel Goncalves
  • Cup cake form
    Patent number: D600496
    Type: Grant
    Filed: March 1, 2009
    Date of Patent: September 22, 2009
    Inventor: Ana Fernandes